Prof. Dr. Horst Domdey

Prior to his activities at BioM, Horst lead the Munich top level clusterprogram m4, taught as professor for biochemistry at the LMU in Munich and founded the biotechnology company MediGene AG.

Besides various other activities, Horst is Chairman of the board of Medigene AG, board member of the Max Delbrück-Centrums for molecular medicine, board member of the Peter and Traudl Engelhorn Foundation and a board member of the Foundation for stem cell research and applied regenerative medicine.

After his doctor in biochemistry, Horst began his career as scientist at various German, Swiss and US institutes like the Max-Planck institute for biochemistry, the ISREC, the USCD and the institute of technology of California